{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T20:41:17Z","timestamp":1791146477461,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"52","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.vaccine.2012.10.043","type":"journal-article","created":{"date-parts":[[2012,11,8]],"date-time":"2012-11-08T20:57:41Z","timestamp":1352408261000},"page":"7652-7657","source":"Crossref","is-referenced-by-count":36,"title":["Pathogen sensors and chemokine receptors in dendritic cell subsets"],"prefix":"10.1016","volume":"30","author":[{"given":"Tsuneyasu","family":"Kaisho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.10.043_bib0005","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nri3247","article-title":"Nucleic acid sensing at the interface between innate and adaptive immunity in vaccination","volume":"12","author":"Desmet","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0010","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/nri2174","article-title":"Genetic analysis of resistance to viral infection","volume":"7","author":"Beutler","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0015","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","article-title":"The chemokine superfamily revisited","volume":"36","author":"Zlotnik","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nri746","article-title":"Mouse and human dendritic cell subtypes","volume":"2","author":"Shortman","year":"2002","journal-title":"Nature Rev Immunol"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0025","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev.immunol.23.021704.115633","article-title":"IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors","volume":"23","author":"Liu","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0030","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.immuni.2010.11.020","article-title":"Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual","volume":"33","author":"Swiecki","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0035","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.immuni.2011.10.014","article-title":"Plasmacytoid dendritic cells are crucial for the initiation of inflammation and T cell immunity in vivo","volume":"35","author":"Takagi","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0040","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1126\/science.1093616","article-title":"Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA","volume":"303","author":"Diebold","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0045","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nri2358","article-title":"Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases","volume":"8","author":"Gilliet","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0050","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/91070","article-title":"Mutation of DNASE1 in people with systemic lupus erythematosus","volume":"28","author":"Yasutomo","year":"2001","journal-title":"Nat Genet"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0055","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/nature05245","article-title":"Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages","volume":"443","author":"Kawane","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0060","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature06116","article-title":"Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide","volume":"449","author":"Lande","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0065","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/ni1457","article-title":"Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE","volume":"8","author":"Tian","year":"2007","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0070","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.immuni.2006.08.010","article-title":"Type I interferon in systemic lupus erythematosus and other autoimmune diseases","volume":"25","author":"Banchereau","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0075","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1182\/blood-2007-04-084210","article-title":"Development of plasmacytoid dendritic cells in bone marrow stromal cell niches requires CXCL12-CXCR4 chemokine signaling","volume":"110","author":"Kohara","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0080","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1182\/blood-2010-03-272096","article-title":"Defect of plasmacytoid dendritic cells in warts, hypogammaglobulinemia, infections, myelokathexis (WHIM) syndrome patients","volume":"116","author":"Tassone","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0085","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.4049\/jimmunol.1002598","article-title":"CCR7 essentially contributes to the homing of plasmacytoid dendritic cells to lymph nodes under steady-state as well as inflammatory conditions","volume":"186","author":"Seth","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0090","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4049\/jimmunol.1200802","article-title":"Constitutive plasmacytoid dendritic cell migration to the splenic white pulp is cooperatively regulated by CCR7- and CXCR4-mediated signaling","volume":"189","author":"Umemoto","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0095","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S0962-8924(02)02330-9","article-title":"The CDM protein DOCK2 in lymphocyte migration","volume":"12","author":"Reif","year":"2002","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0100","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2007-09-112169","article-title":"Differential requirement for DOCK2 in migration of plasmacytoid dendritic cells versus myeloid dendritic cells","volume":"111","author":"Gotoh","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0105","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1084\/jem.20091776","article-title":"Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation","volume":"207","author":"Gotoh","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0110","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0115","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nri1900","article-title":"IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors","volume":"6","author":"Honda","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0120","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature04641","article-title":"IkappaB kinase-alpha is critical for interferon-alpha production induced by Toll-like receptors 7 and 9","volume":"440","author":"Hoshino","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0125","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1084\/jem.192.5.761","article-title":"Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity","volume":"192","author":"Kunkel","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0130","doi-asserted-by":"crossref","first-page":"6562","DOI":"10.1182\/blood-2010-12-326678","article-title":"Identification of CCR9-murine plasmacytoid DC precursors with plasticity to differentiate into conventional DCs","volume":"117","author":"Schlitzer","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0135","doi-asserted-by":"crossref","first-page":"6063","DOI":"10.1182\/blood-2012-03-418400","article-title":"Tissue-specific differentiation of a circulating CCR9-pDC-like common dendritic cell precursor","volume":"119","author":"Schlitzer","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0140","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1073\/pnas.0609180104","article-title":"CCR9 is a homing receptor for plasmacytoid dendritic cells to the small intestine","volume":"104","author":"Wendland","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0145","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1002\/1521-4141(200109)31:9<2547::AID-IMMU2547>3.0.CO;2-J","article-title":"Induction of antigen-specific human CD4(+) T cell anergy by peripheral blood DC2 precursors","volume":"31","author":"Kuwana","year":"2001","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0150","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1182\/blood.V100.2.383","article-title":"Characterization of a new subpopulation of mouse CD8alpha+ B220+ dendritic cells endowed with type 1 interferon production capacity and tolerogenic potential","volume":"100","author":"Martin","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0155","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1046\/j.1365-2567.2003.01606.x","article-title":"Mucosal CD8alpha+ DC, with a plasmacytoid phenotype, induce differentiation and support function of T cells with regulatory properties","volume":"108","author":"Bilsborough","year":"2003","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0160","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.immuni.2008.06.017","article-title":"Plasmacytoid dendritic cells mediate oral tolerance","volume":"29","author":"Goubier","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0165","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/ni.1658","article-title":"CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease","volume":"9","author":"Hadeiba","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0170","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.immuni.2012.01.017","article-title":"Plasmacytoid dendritic cells transport peripheral antigens to the thymus to promote central tolerance","volume":"36","author":"Hadeiba","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0175","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.immuni.2010.01.013","article-title":"Quantitative proteomics reveals subset-specific viral recognition in dendritic cells","volume":"32","author":"Luber","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0180","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1084\/jem.20081370","article-title":"TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events","volume":"205","author":"Cavassani","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0185","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1126\/science.1136080","article-title":"Differential antigen processing by dendritic cell subsets in vivo","volume":"315","author":"Dudziak","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0190","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1126\/science.1164206","article-title":"Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity","volume":"322","author":"Hildner","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0195","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.immuni.2011.06.012","article-title":"CD8alpha(+) dendritic cells are an obligate cellular entry point for productive infection by Listeria monocytogenes","volume":"35","author":"Edelson","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0200","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.immuni.2011.08.008","article-title":"CD8alpha(+) dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites","volume":"35","author":"Mashayekhi","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0205","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1084\/jem.20101159","article-title":"Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells","volume":"208","author":"Fuertes","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0210","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1084\/jem.20101158","article-title":"Type I interferon is selectively required by dendritic cells for immune rejection of tumors","volume":"208","author":"Diamond","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0215","doi-asserted-by":"crossref","first-page":"860","DOI":"10.4049\/jimmunol.165.2.860","article-title":"Repression of IL-2 promoter activity by the novel basic leucine zipper p21SNFT protein","volume":"165","author":"Iacobelli","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0220","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1073\/pnas.0712394105","article-title":"Selective suicide of cross-presenting CD8+ dendritic cells by cytochrome c injection shows functional heterogeneity within this subset","volume":"105","author":"Lin","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0225","doi-asserted-by":"crossref","first-page":"11288","DOI":"10.1073\/pnas.1202208109","article-title":"Conditional ablation of CD205+ conventional dendritic cells impacts the regulation of T-cell immunity and homeostasis in vivo","volume":"109","author":"Fukaya","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0230","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.4049\/jimmunol.1201171","article-title":"Cutting edge Clec9A+ dendritic cells mediate the development of experimental cerebral malaria","volume":"189","author":"Piva","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0235","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.immuni.2009.08.027","article-title":"Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells","volume":"31","author":"Dorner","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0240","doi-asserted-by":"crossref","first-page":"16551","DOI":"10.1074\/jbc.273.26.16551","article-title":"Identification of single C motif-1\/lymphotactin receptor XCR1","volume":"273","author":"Yoshida","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0245","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1084\/jem.20100223","article-title":"The XC chemokine receptor 1 is a conserved selective marker of mammalian cells homologous to mouse CD8{alpha}+ dendritic cells","volume":"207","author":"Crozat","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0250","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1084\/jem.20102327","article-title":"Aire-dependent production of XCL1 mediates medullary accumulation of thymic dendritic cells and contributes to regulatory T cell development","volume":"208","author":"Lei","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0255","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1084\/jem.20092140","article-title":"Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens","volume":"207","author":"Jongbloed","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0260","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1084\/jem.20092618","article-title":"Characterization of human DNGR-1+ BDCA3+ leukocytes as putative equivalents of mouse CD8{alpha}+ dendritic cells","volume":"207","author":"Poulin","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0265","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1084\/jem.20100348","article-title":"Superior antigen cross-presentation and XCR1 expression define human CD11c+ CD141+ cells as homologues of mouse CD8+ dendritic cells","volume":"207","author":"Bachem","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0270","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.bbrc.2010.06.029","article-title":"Conservation of a chemokine system, XCR1 and its ligand, XCL1, between human and mice","volume":"397","author":"Yamazaki","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0275","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1126\/science.1220363","article-title":"TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modification","volume":"337","author":"Oldenburg","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0280","doi-asserted-by":"crossref","first-page":"4411","DOI":"10.4049\/jimmunol.1101717","article-title":"Cutting edge: expression of XCR1 defines mouse lymphoid-tissue resident and migratory dendritic cells of the CD8alpha+ type","volume":"187","author":"Crozat","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0285","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.immuni.2012.04.012","article-title":"Human Tissues contain CD141(hi) cross-presenting dendritic cells with functional homology to mouse CD103(+) nonlymphoid dendritic cells","volume":"37","author":"Haniffa","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0290","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1182\/blood-2012-02-410936","article-title":"Pivotal role of plasmacytoid dendritic cells in inflammation and NK-cell responses after TLR9 triggering in mice","volume":"120","author":"Guillerey","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0295","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.4049\/jimmunol.169.12.6673","article-title":"Cutting edge: differential chemokine production by myeloid and plasmacytoid dendritic cells","volume":"169","author":"Penna","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0300","doi-asserted-by":"crossref","first-page":"6079","DOI":"10.4049\/jimmunol.169.11.6079","article-title":"IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation","volume":"169","author":"Krug","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0305","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1189\/jlb.0603291","article-title":"Virally stimulated plasmacytoid dendritic cells produce chemokines and induce migration of T and NK cells","volume":"7","author":"Megjugorac","year":"2004","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0310","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1182\/blood-2005-07-2965","article-title":"Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors","volume":"107","author":"Piqueras","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0315","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1189\/jlb.0704383","article-title":"Virus overrides the propensity of human CD40L-activated plasmacytoid dendritic cells to produce Th2 mediators through synergistic induction of IFN-{gamma} and Th1 chemokine production","volume":"78","author":"Bendriss-Vermare","year":"2005","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0320","doi-asserted-by":"crossref","first-page":"12597","DOI":"10.1128\/JVI.79.19.12597-12601.2005","article-title":"Human immunodeficiency virus type 1 gp120 and other activation stimuli are highly effective in triggering alpha interferon and CC chemokine production in circulating plasmacytoid but not myeloid dendritic cells","volume":"79","author":"Del Corno","year":"2005","journal-title":"J Virol"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2012.10.043_bib0325","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.it.2010.05.004","article-title":"Trafficking properties of plasmacytoid dendritic cells in health and disease","volume":"31","author":"Sozzani","year":"2010","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0330","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1084\/jem.20031023","article-title":"LPS-TLR4 signaling to IRF-3\/7 and NF-{kappa}B involves the Toll adapters TRAM and TRIF","volume":"198","author":"Fitzgerald","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0335","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/ni.1848","article-title":"Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs","volume":"11","author":"Semmling","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.vaccine.2012.10.043_bib0340","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1084\/jem.20020437","article-title":"The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)\/CXCL12","volume":"198","author":"Vanbervliet","year":"2003","journal-title":"J Exp Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12014892?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12014892?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,5]],"date-time":"2019-07-05T11:43:13Z","timestamp":1562326993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12014892"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":68,"journal-issue":{"issue":"52","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S0264410X12014892"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.10.043","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}